Minutes from Medical Services Advisory Committee and sub-committees

Tanysha B made this Freedom of Information request to Department of Health

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

2 followers

Response to this request is long overdue. By law, under all circumstances, Department of Health should have responded by now (details). You can complain by requesting an internal review.

Dear Department of Health,

I refer to the Medical Services Advisory Commitee and sub-committee meetings on 13-14 February 2020, 2-3 April 2020 and 16-17 April 2020.

http://www.msac.gov.au/internet/msac/pub...

I wish to request the following documents, under the Freedom of Information Act 1982:

1. The minutes of the meetings that took place on
13-14 February - ESC meeting
2-3 April - MSAC meeting
16-17 April - PICO meeting

2. Any documentation relied upon, or otherwise referenced in these meetings

An agency or minister may impose a charge for providing access to a document under s 29 of the FOI Act. I request that the Department waive any charges applicable to this request, on the basis that the release of these documents would be in the public interest (s 29(5)(b)). The Committee's advice directly impacts the health of almost 25 million Australians, and the release of these documents is therefore in the interest of the entire Australian population.

Yours faithfully,

Tanysha B.

image001.png

0K Download

Attention: Tanysha B

I am writing to notify you that the Department of Health (department) has
received your request for access to documents under the Freedom of
Information Act 1982 (Cth) (FOI Act) as follows:

1. The minutes of the meetings that took place on

13-14 February - ESC meeting

2-3 April - MSAC meeting

16-17 April - PICO meeting

2. Any documentation relied upon, or otherwise referenced in these
meetings

Request for extension of time

The department is actively processing your request and is aiming to
finalise it as quickly as possible. However, the department is currently
experiencing an increased workload to manage and respond to the
coronavirus pandemic, with a large amount of resources being diverted to
do so. The content of your request means that any documents that exist
would sit with the line area who has responsibility for the department’s
continued response to the coronavirus.

On this basis, the department is seeking an extension of 30 calendar days,
with a decision to be provided to you no later than COB 20 June 2020.

Next Steps

Could you please advise the department by COB Thursday, 23 April 2020 if
you agree to the request for extension of time?

Kind regards

FOI Team Leader
FOI Team - FOI and Legislation Support Section

[1]cid:image003.png@01D51610.1D98D220

Legal & Assurance Division | Corporate Operations Group

Legal Advice & Legislation Branch

Australian Government Department of Health

T: 02 6289 1666 | E: [2][email address]

GPO Box 9848, Canberra ACT 2601, Australia

The Department of Health acknowledges the Traditional Custodians of
Australia and their continued connection to land, sea and community. We
pay our respects to all Elders past and present.

If you receive this email in error, please delete it and contact the
sender immediately.

-----Original Message-----
From: Tanysha B <[FOI #6298 email]>
Sent: Tuesday, 21 April 2020 1:33 PM
To: FOI <[email address]>
Subject: Freedom of Information request - Minutes from Medical Services
Advisory Committee and sub-committees [SEC=No Protective Marking]

Dear Department of Health,

I refer to the Medical Services Advisory Commitee and sub-committee
meetings on 13-14 February 2020, 2-3 April 2020 and 16-17 April 2020.

[3]http://www.msac.gov.au/internet/msac/pub...

I wish to request the following documents, under the Freedom of
Information Act 1982:

1. The minutes of the meetings that took place on

13-14 February - ESC meeting

2-3 April - MSAC meeting

16-17 April - PICO meeting

2. Any documentation relied upon, or otherwise referenced in these
meetings

An agency or minister may impose a charge for providing access to a
document under s 29 of the FOI Act. I request that the Department waive
any charges applicable to this request, on the basis that the release of
these documents would be in the public interest (s 29(5)(b)). The
Committee's advice directly impacts the health of almost 25 million
Australians, and the release of these documents is therefore in the
interest of the entire Australian population.

Yours faithfully,

Tanysha B.

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[4][FOI #6298 email]

Is [5][Health request email] the wrong address for Freedom of Information
requests to Department of Health? If so, please contact us using this
form:

[6]https://www.righttoknow.org.au/change_re...

This request has been made by an individual using Right to Know. This
message and any reply that you make will be published on the internet.
More information on how Right to Know works can be found at:

[7]https://www.righttoknow.org.au/help/offi...

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

-------------------------------------------------------------------

--------------------------------------------------------------------------

"Important: This transmission is intended only for the use of the
addressee and may contain confidential or legally privileged information.
If you are not the intended recipient, you are notified that any use or
dissemination of this communication is strictly prohibited. If you receive
this transmission in error please notify the author immediately and delete
all copies of this transmission."

References

Visible links
2. mailto:[email address]
3. http://www.msac.gov.au/internet/msac/pub...
4. mailto:[FOI #6298 email]
5. mailto:[Health request email]
6. https://www.righttoknow.org.au/change_re...
7. https://www.righttoknow.org.au/help/offi...

hide quoted sections

Dear FOI,

I agree to an extension of 30 calendar days, with a decision to be provided to me no later than COB 20 June 2020.

Yours sincerely,

Tanysha B

image001.png

0K Download

Dear Tanysha

I refer to your request of 21 April 2020 to the Department of Health
(department) seeking access under the Freedom of Information Act 1982
(Cth) (FOI Act) to the following documents:

1. The minutes of the meetings that took place on

13-14 February - ESC meeting

2-3 April - MSAC meeting

16-17 April - PICO meeting

2. Any documentation relied upon, or otherwise referenced in these
meetings

Scope of request

We note that the scope of your request is relatively broad and, as such,
we would like to discuss whether there is anything you are looking for in
particular and if you would consider narrowing the scope of your request.

In particular, we understand that there are a substantial number of
applications considered at each meeting and there is generally a large
number of documents which inform the committees on each consideration. We
understand that this is likely to make your current request quite
voluminous.

For your awareness, the recorded outcomes of the type of meetings you have
asked about are, as a matter of course, published on the Department’s
website, usually 8-10 weeks after the meetings. For MSAC and ESC the
recorded outcomes are the Public Summary Documents, and for PICO (PASC)
meetings the outcomes are the PICO confirmation documents.

In light of the above, if you consider the Public Summary Documents (which
will be publically available) may not provide the information you are
seeking, we would appreciate if you would consider limiting your request
so that it may be more likely to be able to be processed under the FOI
Act. In particular, you may want to consider limiting the scope by
identifying a particular application(s) you are interested in or a
particular document/type of document which you are seeking. To assist in
your consideration, below is an outline of the applications considered the
dates you have referred to in your request:

13-14 February ESC Meeting

[1]Application 1192.3 - Reduction of mitral regurgitation through tissue
approximation, using transvenous/transeptal techniques - Resubmission
[2]Application 1344.2 - Assessment of foot and ankle services by podiatric
surgeons – Resubmission
[3]Application 1420.1 - Extracorporeal photopheresis for treatment of
cutaneous T-cell lymphoma - Resubmission
[4]Application 1429.1 - Targeted Intraoperative Radiotherapy (T-IORT) for
early-stage breast cancer - Resubmission
[5]Application 1466 – Vertebroplasty for severely painful osteoporotic
vertebral fractures
[6]Application 1485.1 – Sentinel Lymph Node Biopsy for intermediate
thickness melanoma - Resubmission
[7]Application 1553 –Transmural fixation of aortic endograft adjunct to
endovascular aneurysm repair using helical anchors
[8]Application 1559 –- Endoscopic Mucosal Resection (EMR) to differentiate
colon polyp from colorectal cancer
[9]Application 1564 - Chronic Inflammatory Demyelinating Polyneuropathy
(CIDP)
[10]Application 1566 – Myasthenia Gravis
[11]Application 1570 - PD-L1 (Programmed death ligand 1)
immunohistochemistry (IHC) testing for access to atezolizumab as
first-line therapy for patients with locally advanced or metastatic
triple-negative breast cancer (TNBC)
[12]Application 1572 - Diagnosis of hypertension using ambulatory blood
pressure monitoring in patients with clinic blood pressure ≥ 140/90mmHg
and ≤ 180/110mmHg

3 April MSAC Meeting

[13]Application 1192.3 - Reduction of mitral regurgitation through tissue
approximation, using transvenous/transeptal techniques - Resubmission
[14]Application 1344.2 - Assessment of foot and ankle services by
podiatric surgeons – Resubmission
[15]Application 1420.1 - Extracorporeal photopheresis for treatment of
cutaneous T-cell lymphoma - Resubmission
[16]Application 1429.1 - Targeted Intraoperative Radiotherapy (T-IORT) for
early-stage breast cancer - Resubmission
[17]Application 1466 – Vertebroplasty for severely painful osteoporotic
vertebral fractures
[18]Application 1485.1 – Sentinel Lymph Node Biopsy for intermediate
thickness melanoma - Resubmission
[19]Application 1553 –Transmural fixation of aortic endograft adjunct to
endovascular aneurysm repair using helical anchors
[20]Application 1564 – Immunoglobulin for Chronic Inflammatory
Demyelinating Polyneuropathy (CIDP)
[21]Application 1566 – Immunoglobulin for Myasthenia Gravis
[22]Application 1570 - PD-L1 (Programmed death ligand 1)
immunohistochemistry (IHC) testing for access to atezolizumab as
first-line therapy for patients with locally advanced or metastatic
triple-negative breast cancer (TNBC)
[23]Application 1572 - Diagnosis of hypertension using ambulatory blood
pressure monitoring in patients with clinic blood pressure ≥ 140/90mmHg
and ≤ 180/110mmHg
[24]Application 1607 – 17p deletion testing for access to acalabrutinib in
patients with relapsed or refractory chronic lymphocytic leukaemia
[25]Application 1621 – Amendment to MBS Item 73344 for c-ROS
proto-oncogene 1 (ROS1) fluorescence in situ hybridisation (FISH) testing
to identify ROSI to determine patient eligibility for entrectinib under
the Pharmaceutical Benefits Scheme (PBS)

17 April PASC meeting

[26]1522 – PDL1 immunohistochemistry testing for access to pembrolizumab
as first-line therapy for patients with recurrent (not amenable to local
treatment) or metastatic head and neck squamous cell carcinoma

[27]1585 – Genetic testing for the diagnosis of early-onset or familial
neuromuscular disorders

[28]1600 – Genetic testing for inherited kidney disease (other than Alport
syndrome)

[29]1608 – Human tissue (amnion membrane) for topical treatment of
ophthalmic disorders, and wound

[30]1613 – Permanent acute coronary syndrome event detector (insertion,
removal or replacement of) for monitoring of the heart's electrical
activity

[31]1614 – Magnetic resonance-guided focused ultrasound for patients with
essential tremor

[32]1615 – Transcatheter occlusion of left atrial appendage for patients
with non-valvular atrial fibrillation

[33]1617 – BRAF V600 mutation testing to determine eligibility for PBS
access to Braftovi® (encorafenib) in patients with metastatic colorectal
cancer (stage IV)

[34]1618 – Testing of tumour prostate tissue to detect BRCA1/2 or ATM gene
mutations in men with metastatic castration-resistant prostate cancer to
determine eligibility for PBS olaparib

[35]1619 – Testing of blood to detect germline BRCA1 or BRCA2 gene
mutations in patients with metastatic pancreatic cancer to determine
eligibility for PBS olaparib

[36]1620 – Magnetic resonance image guided radiation therapy

Next steps

We would appreciate if you could please advise if you are willing to
narrow the scope of your request, and if so, the new scope of your
request, by COB 4 April 2020.

Kind regards

FOI Team - FOI and Legislation Support Section

[37]cid:image003.png@01D51610.1D98D220

Legal & Assurance Division | Corporate Operations Group

Legal Advice & Legislation Branch

Australian Government Department of Health

T: 02 6289 1666 | E: [38][email address]

GPO Box 9848, Canberra ACT 2601, Australia

The Department of Health acknowledges the Traditional Custodians of
Australia and their continued connection to land, sea and community. We
pay our respects to all Elders past and present.

If you receive this email in error, please delete it and contact the
sender immediately.

--------------------------------------------------------------------------

References

hide quoted sections

image001.png

0K Download

Dear Tanysha

I refer to the below email sent to you on 1 May 2020 regarding the scope
of your FOI request and note that you have not yet provided a response to
this email.

As such, I ask that you please advise if you are willing to narrow the
scope of your request, and if so, the new scope of your request. If a
response is not received from you by COB 11 May 2020, I will take this to
mean that you have withdrawn your FOI request.

Kind regards

FOI Team - FOI and Legislation Support Section

[1]cid:image003.png@01D51610.1D98D220

Legal & Assurance Division | Corporate Operations Group

Legal Advice & Legislation Branch

Australian Government Department of Health

T: 02 6289 1666 | E: [2][email address]

GPO Box 9848, Canberra ACT 2601, Australia

The Department of Health acknowledges the Traditional Custodians of
Australia and their continued connection to land, sea and community. We
pay our respects to all Elders past and present.

If you receive this email in error, please delete it and contact the
sender immediately.

From: FOI <[email address]>
Sent: Friday, 1 May 2020 1:41 PM
To: 'Tanysha B' <[FOI #6298 email]>
Cc: FOI <[email address]>
Subject: FOI Request 1655 - scope of request [SEC=OFFICIAL]

Dear Tanysha

I refer to your request of 21 April 2020 to the Department of Health
(department) seeking access under the Freedom of Information Act 1982
(Cth) (FOI Act) to the following documents:

1. The minutes of the meetings that took place on

13-14 February - ESC meeting

2-3 April - MSAC meeting

16-17 April - PICO meeting

2. Any documentation relied upon, or otherwise referenced in these
meetings

Scope of request

13-14 February ESC Meeting

[3]Application 1192.3 - Reduction of mitral regurgitation through tissue
approximation, using transvenous/transeptal techniques - Resubmission
[4]Application 1344.2 - Assessment of foot and ankle services by podiatric
surgeons – Resubmission
[5]Application 1420.1 - Extracorporeal photopheresis for treatment of
cutaneous T-cell lymphoma - Resubmission
[6]Application 1429.1 - Targeted Intraoperative Radiotherapy (T-IORT) for
early-stage breast cancer - Resubmission
[7]Application 1466 – Vertebroplasty for severely painful osteoporotic
vertebral fractures
[8]Application 1485.1 – Sentinel Lymph Node Biopsy for intermediate
thickness melanoma - Resubmission
[9]Application 1553 –Transmural fixation of aortic endograft adjunct to
endovascular aneurysm repair using helical anchors
[10]Application 1559 –- Endoscopic Mucosal Resection (EMR) to
differentiate colon polyp from colorectal cancer
[11]Application 1564 - Chronic Inflammatory Demyelinating Polyneuropathy
(CIDP)
[12]Application 1566 – Myasthenia Gravis
[13]Application 1570 - PD-L1 (Programmed death ligand 1)
immunohistochemistry (IHC) testing for access to atezolizumab as
first-line therapy for patients with locally advanced or metastatic
triple-negative breast cancer (TNBC)
[14]Application 1572 - Diagnosis of hypertension using ambulatory blood
pressure monitoring in patients with clinic blood pressure ≥ 140/90mmHg
and ≤ 180/110mmHg

3 April MSAC Meeting

[15]Application 1192.3 - Reduction of mitral regurgitation through tissue
approximation, using transvenous/transeptal techniques - Resubmission
[16]Application 1344.2 - Assessment of foot and ankle services by
podiatric surgeons – Resubmission
[17]Application 1420.1 - Extracorporeal photopheresis for treatment of
cutaneous T-cell lymphoma - Resubmission
[18]Application 1429.1 - Targeted Intraoperative Radiotherapy (T-IORT) for
early-stage breast cancer - Resubmission
[19]Application 1466 – Vertebroplasty for severely painful osteoporotic
vertebral fractures
[20]Application 1485.1 – Sentinel Lymph Node Biopsy for intermediate
thickness melanoma - Resubmission
[21]Application 1553 –Transmural fixation of aortic endograft adjunct to
endovascular aneurysm repair using helical anchors
[22]Application 1564 – Immunoglobulin for Chronic Inflammatory
Demyelinating Polyneuropathy (CIDP)
[23]Application 1566 – Immunoglobulin for Myasthenia Gravis
[24]Application 1570 - PD-L1 (Programmed death ligand 1)
immunohistochemistry (IHC) testing for access to atezolizumab as
first-line therapy for patients with locally advanced or metastatic
triple-negative breast cancer (TNBC)
[25]Application 1572 - Diagnosis of hypertension using ambulatory blood
pressure monitoring in patients with clinic blood pressure ≥ 140/90mmHg
and ≤ 180/110mmHg
[26]Application 1607 – 17p deletion testing for access to acalabrutinib in
patients with relapsed or refractory chronic lymphocytic leukaemia
[27]Application 1621 – Amendment to MBS Item 73344 for c-ROS
proto-oncogene 1 (ROS1) fluorescence in situ hybridisation (FISH) testing
to identify ROSI to determine patient eligibility for entrectinib under
the Pharmaceutical Benefits Scheme (PBS)

17 April PASC meeting

[28]1522 – PDL1 immunohistochemistry testing for access to pembrolizumab
as first-line therapy for patients with recurrent (not amenable to local
treatment) or metastatic head and neck squamous cell carcinoma

[29]1585 – Genetic testing for the diagnosis of early-onset or familial
neuromuscular disorders

[30]1600 – Genetic testing for inherited kidney disease (other than Alport
syndrome)

[31]1608 – Human tissue (amnion membrane) for topical treatment of
ophthalmic disorders, and wound

[32]1613 – Permanent acute coronary syndrome event detector (insertion,
removal or replacement of) for monitoring of the heart's electrical
activity

[33]1614 – Magnetic resonance-guided focused ultrasound for patients with
essential tremor

[34]1615 – Transcatheter occlusion of left atrial appendage for patients
with non-valvular atrial fibrillation

[35]1617 – BRAF V600 mutation testing to determine eligibility for PBS
access to Braftovi® (encorafenib) in patients with metastatic colorectal
cancer (stage IV)

[36]1618 – Testing of tumour prostate tissue to detect BRCA1/2 or ATM gene
mutations in men with metastatic castration-resistant prostate cancer to
determine eligibility for PBS olaparib

[37]1619 – Testing of blood to detect germline BRCA1 or BRCA2 gene
mutations in patients with metastatic pancreatic cancer to determine
eligibility for PBS olaparib

[38]1620 – Magnetic resonance image guided radiation therapy

Next steps

We would appreciate if you could please advise if you are willing to
narrow the scope of your request, and if so, the new scope of your
request, by COB 4 April 2020.

Kind regards

FOI Team - FOI and Legislation Support Section

[39]cid:image003.png@01D51610.1D98D220

Legal & Assurance Division | Corporate Operations Group

Legal Advice & Legislation Branch

Australian Government Department of Health

T: 02 6289 1666 | E: [40][email address]

GPO Box 9848, Canberra ACT 2601, Australia

The Department of Health acknowledges the Traditional Custodians of
Australia and their continued connection to land, sea and community. We
pay our respects to all Elders past and present.

If you receive this email in error, please delete it and contact the
sender immediately.

--------------------------------------------------------------------------

References

hide quoted sections

Dear FOI,

If the meeting minutes will be publicly available then that’s fine. I formally withdraw my FOI.

Yours sincerely,

Tanysha B

2 followers

Right to Know

Minutes from Medical Services Advisory Committee and sub-committees

1 Attachment

1 Attachment

1 Attachment

Want to know something?

Act on what you've learnt

Requests like this

Request for PASC meeting minutes 7-8/12/23

All documents and minutes (PASC, ESC & MSAC) relating to MSAC 1530

What are all our .gov.au domains?

Business case for the Points Based Activation System

Request for PASC meeting minutes 7-8/12/23

Question Time Briefs

Minutes of AHPPC Meeting 03 April 2020

Evidence of efficacy of Escitalopram

Post-listing Review of Surgical Guides and Biomodels currently listed on the Prostheses List - Final Report

ARPANSA meeting minutes

Right to Know